Diagnos (TSXV:ADK) Common Stock : C$43.04 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Diagnos Common Stock?

Diagnos's quarterly common stock increased from Jun. 2024 (C$39.00 Mil) to Sep. 2024 (C$41.51 Mil) and increased from Sep. 2024 (C$41.51 Mil) to Dec. 2024 (C$43.04 Mil).

Diagnos's annual common stock increased from Mar. 2022 (C$35.68 Mil) to Mar. 2023 (C$35.92 Mil) and increased from Mar. 2023 (C$35.92 Mil) to Mar. 2024 (C$37.70 Mil).

Diagnos Common Stock Historical Data

The historical data trend for Diagnos's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Common Stock Chart

Diagnos Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Common Stock

Get a 7-Day Free Trial

33.67

34.76

35.68

35.92

37.70

Diagnos Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															37.00	37.70	39.00	41.51	43.04

Diagnos Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Diagnos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

DGNOF:USA

Address

7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7

Website

https://www.diagnos.com

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.

Executives

Tristram Coffin	10% Security Holder
Marc-andré Massue	Senior Officer
Robert Dunn	Director
Francis Bellido	Director
Vincent Duhamel	Director
André Larente	Director, Senior Officer
Guillermo Moreno Robles	Senior Officer
Georges Hébert	Director
Gestion Maurice Pinsonnault Inc.	10% Security Holder

Diagnos Headlines

No Headlines